Zhe Cai

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Molecular Docking

Top Venues

The EMBO journal

Cell death and differentiation

Mediators of inflammation

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Xing He, Haowei He, Zitong Hou, Zheyu Wang, Qinglin Shi, Tao Zhou, Yaoxing Wu, Yunfei Qin, Jun Wang, Zhe Cai, Jun Cui, Shouheng Jin
ER-phagy restrains inflammatory responses through its receptor UBAC2. The EMBO journal (2024)
Lingli Zhou, Xing He, Liqiu Wang, Ping Wei, Zhe Cai, Song Zhang, Shouheng Jin, Hua-Song Zeng, Jun Cui
Palmitoylation restricts SQSTM1/p62-mediated autophagic degradation of NOD2 to modulate inflammation. Cell death and differentiation 29 (8) (2022)
Song Zhang, Wenxu Pan, Hongli Wang, Cheng Zhi, Yanhao Lin, Ping Wu, Qi Ren, Ping Wei, Rui Chen, Feng Li, Ying Xie, Chun Kwok Wong, Hong Tang, Zhe Cai, Wanfu Xu, Hua-Song Zeng
Vitronectin, a Novel Urinary Proteomic Biomarker, Promotes Cell Pyroptosis in Juvenile Systemic Lupus Erythematosus. Mediators of inflammation 2022 (2022)
Man Chu, Ting Gao, Xu Zhang, Wulin Kang, Yu Feng, Zhe Cai, Ping Wu
Elucidation of Potential Targets of San-Miao-San in the Treatment of Osteoarthritis Based on Network Pharmacology and Molecular Docking Analysis. Evidence-based complementary and alternative medicine : eCAM 2022 (2022)
Zhe Cai, Song Zhang, Ping Wu, Qi Ren, Ping Wei, Ming Hong, Yu Feng, Chun Kwok Wong, Hong Tang, Huasong Zeng
A novel potential target of IL-35-regulated JAK/STAT signaling pathway in lupus nephritis. Clinical and translational medicine 11 (2) (2021)